2-Deoxy-d-Glucose Can Complement Doxorubicin and Sorafenib to Suppress the Growth of Papillary Thyroid Carcinoma Cells

Tumor cells display a shift in energy metabolism from oxidative phosphorylation to aerobic glycolysis. A subset of papillary thyroid carcinoma (PTC) is refractory to surgery and radioactive iodine ablation. Doxorubicin and sorafenib are the drugs of choice for treating advanced thyroid cancer but bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuo-Yu, Wei, Yau-Huei, Shieh, Dar-Bin, Lin, Li-Ling, Cheng, Shih-Ping, Wang, Pei-Wen, Chuang, Jiin-Haur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489888/
https://www.ncbi.nlm.nih.gov/pubmed/26134286
http://dx.doi.org/10.1371/journal.pone.0130959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489888/
https://www.ncbi.nlm.nih.gov/pubmed/26134286
http://dx.doi.org/10.1371/journal.pone.0130959

Ejemplares similares